We assessed the commercial viability of Aritex’s novel menstrual care product ahead of its first funding round. Aritex needed a credible, staged route to market for investor conversations. We analysed the market opportunity and customer segments, mapped competitors and positioning, and recommended a direct-to-consumer launch in the UK before moving into pharmacy and supermarket retail. We also covered pricing, the manufacturing and supply chain pathway, international expansion, investment readiness, and a phased implementation roadmap.